Andreas Hinsen

Partner | Attorney at Law
T. +41 58 510 92 50 | +41 79 792 78 12
andreas.hinsen@advestra.ch
vCard
LinkedIn

Andreas' practice focuses on domestic and cross-border M&A transactions, corporate governance, restructurings as well as general corporate and stock exchange laws.

Andreas has broad experience in private equity and venture capital transactions and has advised on a wide range of corporate transactions, including joint ventures, internal restructurings, shareholder agreements, growth capital investments and public-to-private deals. He also frequently advises on general corporate law matters and real estate transactions.

Prior to joining Advestra, Andreas worked at two leading Swiss law firms as well as a leading New York law firm.

Andreas is ranked by both IFLR1000 and Legal500 and listed as rising star by Expert Guides in the areas of Corporate/M&A/Private Equity since 2021.

Selected Deal Highlights

Advising Lonza on the divestment of its Capsules & Health Ingredients (CHI) business
Advising SANDOW on the acquisition of ARCHITONIC
Advising Pallas Athene on the mandatory takeover offer to the shareholders of Ultima Capital AG
Advising the sellers on the sale of IntiQuan AG to ProductLife Group
Advising ENR Russia Invest SA on the public tender offer of its majority shareholder Valartis
Advising eMolecules Inc. and Avista Healthcare Partners on the acquisition of Synple Chem AG
Advising funds affiliated with Perceptive Advisors on the acquisition of a portfolio of preclinical assets and launch of Neurosterix
Advising the shareholders of RMB Group on the strategic partnership with eevolve
Advising Marc O'Polo on the acquisition of the Swiss business from distribution partner Bollag-Guggenheim
Advising Glencore, CPP Investments and BCI, as shareholders, in Viterra Ltd.'s business combination with Bunge Ltd
Advising Catalyst Pharmaceuticals on license to vamorolone and equity investment in Santhera Pharmaceuticals
Advising Ironwood Pharmaceuticals on its public tender offer for VectivBio
Advising various venture capital and private equity firms in their investments in Switzerland, including Revelation Partners, Carbyne Equity, Tristan Capital or XTX Ventures